scispace - formally typeset
I

Ichiro Ono

Researcher at Sapporo Medical University

Publications -  90
Citations -  2159

Ichiro Ono is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Wound healing & Basic fibroblast growth factor. The author has an hindex of 27, co-authored 89 publications receiving 2070 citations.

Papers
More filters
Journal ArticleDOI

A study on bone induction in hydroxyapatite combined with bone morphogenetic protein.

TL;DR: The results revealed that the alkali phosphatase (AL-P) activity of the pellets was elevated only in those of the bone morphogenetic protein group, and the increase in bone mineral density was the most remarkable in the bone Morphogenetic Protein group rather than the control group.
Journal ArticleDOI

Basic fibroblast growth factor reduces scar formation in acute incisional wounds

TL;DR: Postoperative administration of bFGF inhibited hypertrophic scarring and widening of remaining scars without any serious side effects.
Journal ArticleDOI

Studies on cytokines related to wound healing in donor site wound fluid

TL;DR: It is increased the likelihood that film or hydrocolloid dressings will be used more frequently in the future for treatment of burn wounds, ulcers or donor-site wounds since these dressings were shown to be more capable of retaining cytokines, particularly intrinsic growth factors secreted at the wound site.
Journal ArticleDOI

Three-dimensional analysis of craniofacial bones using three-dimensional computer tomography

TL;DR: The three-dimensional (3D) deformities in patients with congenital facial anomalies, such as cleft lip and palate or hemifacial microsomia, are studied using 3D CT images and the 'skeletograms', which present deformities of craniofacial bones in detail as a 3D wire frame model, are prepared for detailed analysis of the cranioFacial bones' deformities.
Journal ArticleDOI

Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy

TL;DR: The results confirm the clinical usefulness of gene therapy for bone formation, using the BMP-2 gene combined with cationic liposomes as a vector and it is possible that the effects of administering the B MP-2 genes will be improved by specializing the microstructure of scaffold for gene therapy.